mc38 cell line Search Results


90
KU Leuven mc38 cells
Mc38 Cells, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/colon+carcinoma+cell+line+mc38/pm37957306-330-0-8
Average 90 stars, based on 1 article reviews
mc38 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Crown Bioscience syngeneic mc38 mouse xenograft models
Syngeneic Mc38 Mouse Xenograft Models, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/human+pd+l1+expressing+mc38+tumor+cell+line/us12285430-3691-13-33
Average 90 stars, based on 1 article reviews
syngeneic mc38 mouse xenograft models - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Wuhan Fine Biotech mc38 murine colon carcinoma cell line
Mc38 Murine Colon Carcinoma Cell Line, supplied by Wuhan Fine Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/the+mc38+cell+line/pm35967466-46-1-10
Average 90 stars, based on 1 article reviews
mc38 murine colon carcinoma cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Absolute Biotech mc38 (kerafast) cells
(A) <t>MC38</t> tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.
Mc38 (Kerafast) Cells, supplied by Absolute Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mc38+colon+carcinoma+cell+line/pmc07098715-272-0-1
Average 90 stars, based on 1 article reviews
mc38 (kerafast) cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
POSTECH Inc mc38
(A) <t>MC38</t> tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.
Mc38, supplied by POSTECH Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mc38+cell+line/pmc07453903-458-0-8
Average 90 stars, based on 1 article reviews
mc38 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Jiangsu Hengrui Medicine colon adenocarcinoma cell line mc38
(A) <t>MC38</t> tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.
Colon Adenocarcinoma Cell Line Mc38, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/colon+adenocarcinoma+cell+line+mc38/pmc10188465-116-3-9
Average 90 stars, based on 1 article reviews
colon adenocarcinoma cell line mc38 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioVector Inc mc38-ova cell line
(A) <t>MC38</t> tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.
Mc38 Ova Cell Line, supplied by BioVector Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mc38+ova+cell+line/pmc08014392-124-3-21
Average 90 stars, based on 1 article reviews
mc38-ova cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Innovent Biologics mouse mc38 colon cancer cell line
Triple Treatment Is Also Effective in Mouse <t>MC38</t> Colon Cancer
Mouse Mc38 Colon Cancer Cell Line, supplied by Innovent Biologics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mouse+mc38+colon+cancer+cell+line/pmc06319306-429-0-9
Average 90 stars, based on 1 article reviews
mouse mc38 colon cancer cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nanjing Galaxy Biotechnology Co Ltd mc38 cells wt
Triple Treatment Is Also Effective in Mouse <t>MC38</t> Colon Cancer
Mc38 Cells Wt, supplied by Nanjing Galaxy Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/hpd+l1+mc38+cell+line/pmc09662884-202-8-20
Average 90 stars, based on 1 article reviews
mc38 cells wt - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc mc38 colon cancer cell line
Triple Treatment Is Also Effective in Mouse <t>MC38</t> Colon Cancer
Mc38 Colon Cancer Cell Line, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mc38+colon+cancer+cell+line/pm36923938-46-1-9
Average 90 stars, based on 1 article reviews
mc38 colon cancer cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Penn Veterinary Supply Inc mouse cell line mc38
(A and B) Tumor growth (A) and survival curves (B) of C57BL/6J mice inoculated with control or HRS KO B16F10 melanoma cells. (C and D) Tumor growth (C) and survival curves (D) of athymic nude mice inoculated with control or HRS KO B16F10 melanoma cells. (E and F) Tumor growth (E) and survival curves (F) of C57BL/6J mice inoculated with control or HRS KD <t>MC38</t> colon cancer cells. (G and H) Tumor growth (G) and survival curves (H) of athymic nude mice inoculated with control or HRS KD MC38 colon cancer cells. (I and J) Tumor growth (I) and survival curves (J) of C57BL/6J mice inoculated with control or HRS KO B16F10 cells, and the mice were intraperitoneally injected with isotype or anti-CD8 antibodies. (K and L) Tumor growth (K) and survival curves (L) of C57BL/6J mice inoculated with control, HRS KO B16, B2M KO, or HRS B2M double KO (dKO) B16F10 cells. Data represent the mean ± SEM; n = 7 or 8 immunocompetent C57BL/6J mice per group, n = 5 or 7 athymic nude mice per group. The p values were determined by two-way ANOVA (A, C, E, G, I, and K) or log-rank test (B, D, F, H, J, and L). See also and .
Mouse Cell Line Mc38, supplied by Penn Veterinary Supply Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mouse+cell+line+mc38/pmc10748463-80-0-8
Average 90 stars, based on 1 article reviews
mouse cell line mc38 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank mouse colon carcinoma cell lines mc-38
(A and B) Tumor growth (A) and survival curves (B) of C57BL/6J mice inoculated with control or HRS KO B16F10 melanoma cells. (C and D) Tumor growth (C) and survival curves (D) of athymic nude mice inoculated with control or HRS KO B16F10 melanoma cells. (E and F) Tumor growth (E) and survival curves (F) of C57BL/6J mice inoculated with control or HRS KD <t>MC38</t> colon cancer cells. (G and H) Tumor growth (G) and survival curves (H) of athymic nude mice inoculated with control or HRS KD MC38 colon cancer cells. (I and J) Tumor growth (I) and survival curves (J) of C57BL/6J mice inoculated with control or HRS KO B16F10 cells, and the mice were intraperitoneally injected with isotype or anti-CD8 antibodies. (K and L) Tumor growth (K) and survival curves (L) of C57BL/6J mice inoculated with control, HRS KO B16, B2M KO, or HRS B2M double KO (dKO) B16F10 cells. Data represent the mean ± SEM; n = 7 or 8 immunocompetent C57BL/6J mice per group, n = 5 or 7 athymic nude mice per group. The p values were determined by two-way ANOVA (A, C, E, G, I, and K) or log-rank test (B, D, F, H, J, and L). See also and .
Mouse Colon Carcinoma Cell Lines Mc 38, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mc38+cell+line/mouse+colon+carcinoma+cell+lines+mc+38/pm38630304-40-1-10
Average 90 stars, based on 1 article reviews
mouse colon carcinoma cell lines mc-38 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) MC38 tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.

Journal: JCI Insight

Article Title: Multipanel mass cytometry reveals anti–PD-1 therapy–mediated B and T cell compartment remodeling in tumor-draining lymph nodes

doi: 10.1172/jci.insight.132286

Figure Lengend Snippet: (A) MC38 tumor cells were injected subcutaneously at day 0 (D0) in the right hind limb of C57BL/6 mice, and either isotype (ISO) or PD-1 antibody (PD-1) was administered intraperitoneally on D14 and D18. Right inguinal lymph nodes were harvested on D21 for analysis. Lymph nodes at the same location from normal, non–tumor-bearing mice (NL) were used as additional control comparators. (B) Lymph nodes were weighed on D21 upon harvest, and (C) absolute number of cells was counted from each lymph node. Mean ± SD (n = 5) are shown for both plots. (D) Schematic shows how lymph nodes from each respective group (Normal LN, non–tumor-bearing normal mice; tdLN Isotype, isotype-treated tumor-bearing mice; tdLN PD-1, PD-1–antibody–treated tumor-bearing mice) were barcoded with a specific CD45 antibody tagged with a unique metal to be multiplexed and stained with a T or B cell subtyping mass cytometry panel. Results for repeated-measures ANOVA followed by pairwise testing are shown as FDR-adjusted *P ≤ 0.05; **P ≤ 0.01; and ***P ≤ 0.005.

Article Snippet: MC38 (Kerafast) cells were maintained in DMEM-based medium containing 10% FBS, 1% l -glutamine, 100 U/mL penicillin/streptomycin, 10 mM HEPES, 1 mM sodium pyruvate, and 0.1 mM nonessential amino acids (Life Technologies) in 5% CO 2 at 37°C.

Techniques: Injection, Staining, Mass Cytometry

Triple Treatment Is Also Effective in Mouse MC38 Colon Cancer

Journal: Molecular Therapy

Article Title: Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

doi: 10.1016/j.ymthe.2018.11.010

Figure Lengend Snippet: Triple Treatment Is Also Effective in Mouse MC38 Colon Cancer

Article Snippet: Mouse MC38 colon cancer cell line was provided by Innovent Biologics (Suzhou, Jiangsu, China).

Techniques:

(A and B) Tumor growth (A) and survival curves (B) of C57BL/6J mice inoculated with control or HRS KO B16F10 melanoma cells. (C and D) Tumor growth (C) and survival curves (D) of athymic nude mice inoculated with control or HRS KO B16F10 melanoma cells. (E and F) Tumor growth (E) and survival curves (F) of C57BL/6J mice inoculated with control or HRS KD MC38 colon cancer cells. (G and H) Tumor growth (G) and survival curves (H) of athymic nude mice inoculated with control or HRS KD MC38 colon cancer cells. (I and J) Tumor growth (I) and survival curves (J) of C57BL/6J mice inoculated with control or HRS KO B16F10 cells, and the mice were intraperitoneally injected with isotype or anti-CD8 antibodies. (K and L) Tumor growth (K) and survival curves (L) of C57BL/6J mice inoculated with control, HRS KO B16, B2M KO, or HRS B2M double KO (dKO) B16F10 cells. Data represent the mean ± SEM; n = 7 or 8 immunocompetent C57BL/6J mice per group, n = 5 or 7 athymic nude mice per group. The p values were determined by two-way ANOVA (A, C, E, G, I, and K) or log-rank test (B, D, F, H, J, and L). See also and .

Journal: Cell reports

Article Title: HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

doi: 10.1016/j.celrep.2023.113352

Figure Lengend Snippet: (A and B) Tumor growth (A) and survival curves (B) of C57BL/6J mice inoculated with control or HRS KO B16F10 melanoma cells. (C and D) Tumor growth (C) and survival curves (D) of athymic nude mice inoculated with control or HRS KO B16F10 melanoma cells. (E and F) Tumor growth (E) and survival curves (F) of C57BL/6J mice inoculated with control or HRS KD MC38 colon cancer cells. (G and H) Tumor growth (G) and survival curves (H) of athymic nude mice inoculated with control or HRS KD MC38 colon cancer cells. (I and J) Tumor growth (I) and survival curves (J) of C57BL/6J mice inoculated with control or HRS KO B16F10 cells, and the mice were intraperitoneally injected with isotype or anti-CD8 antibodies. (K and L) Tumor growth (K) and survival curves (L) of C57BL/6J mice inoculated with control, HRS KO B16, B2M KO, or HRS B2M double KO (dKO) B16F10 cells. Data represent the mean ± SEM; n = 7 or 8 immunocompetent C57BL/6J mice per group, n = 5 or 7 athymic nude mice per group. The p values were determined by two-way ANOVA (A, C, E, G, I, and K) or log-rank test (B, D, F, H, J, and L). See also and .

Article Snippet: Mouse cell line: MC38 , Serge Y. Fuchs, Penn Veterinary School of Medicine , PMID: 32807917; RRID:CVCL_B288.

Techniques: Control, Injection

(A and B) Immunohistochemistry (A) with quantification (B) of CD45 + immune cells (left) and CD8 + T cells (right) in control and HRS KO B16F10 tumors. (C) The infiltration of CD4 + (left) and CD8 + (right) lymphocytes (tumor-infiltrating lymphocytes [TILs]) from control and HRS KO B16F10 tumors in C57BL/6J mice. (D) The expression of Ki-67 (left) and GzmB (right) by CD8 + TILs from control and HRS KO B16F10 tumors. (E) The infiltration of CD4 + (left) and CD8 + (right) TILs from control and HRS KD MC38 colon tumors in C57BL/6J mice. (F) The expression of Ki-67 (left) and GzmB (right) by CD8 + TILs from control and HRS KD MC38 colon tumors. Data represent the mean ± SD; n = 7 or 8 mice per group. The p values were determined by unpaired Student’s t test (B–F). See also .

Journal: Cell reports

Article Title: HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

doi: 10.1016/j.celrep.2023.113352

Figure Lengend Snippet: (A and B) Immunohistochemistry (A) with quantification (B) of CD45 + immune cells (left) and CD8 + T cells (right) in control and HRS KO B16F10 tumors. (C) The infiltration of CD4 + (left) and CD8 + (right) lymphocytes (tumor-infiltrating lymphocytes [TILs]) from control and HRS KO B16F10 tumors in C57BL/6J mice. (D) The expression of Ki-67 (left) and GzmB (right) by CD8 + TILs from control and HRS KO B16F10 tumors. (E) The infiltration of CD4 + (left) and CD8 + (right) TILs from control and HRS KD MC38 colon tumors in C57BL/6J mice. (F) The expression of Ki-67 (left) and GzmB (right) by CD8 + TILs from control and HRS KD MC38 colon tumors. Data represent the mean ± SD; n = 7 or 8 mice per group. The p values were determined by unpaired Student’s t test (B–F). See also .

Article Snippet: Mouse cell line: MC38 , Serge Y. Fuchs, Penn Veterinary School of Medicine , PMID: 32807917; RRID:CVCL_B288.

Techniques: Immunohistochemistry, Control, Expressing

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

doi: 10.1016/j.celrep.2023.113352

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Mouse cell line: MC38 , Serge Y. Fuchs, Penn Veterinary School of Medicine , PMID: 32807917; RRID:CVCL_B288.

Techniques: Virus, Recombinant, SYBR Green Assay, Staining, shRNA, Plasmid Preparation, Software, CRISPR